Intervention With General Practitioners to Improve Women's Participation in Cervical Cancer Screening

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age25-65
SponsorCentre Hospitalier Intercommunal Creteil

About this trial

In France, cervical cancer is the 12th most common female cancer with nearly 3,000 new cases per year.

Since 2018, a national Organized Cervical Cancer Screening program (DOCCU) has been set up and concerns all asymptomatic women aged 25 to 65.

This program, managed by the Regional Cancer Screening Coordination Centers (CRCDC), invites women who have not taken a sample within the recommended time frame to consult for screening. However, only 59% of patients participated.

The intervention of the general practitioner, an essential player in prevention, could allow for better awareness.

The objective of the INDIGO study is to evaluate the effectiveness of the intervention of a general practitioner on the participation rate in the DOCCU of patients who are not up to date with their screening.

Eligibility criteria

Qualifiers

Woman aged 25 to 65 living in Ile-De-France

Eligible for DOCCU (not hysterectomized, not followed for a pre-cancerous or cancerous lesion of the cervix)

Having declared the investigating general practitioner as a treating physician (MT) and whose MT practices in the territory of a CPTS in the UPEC area

Affiliate to a social security scheme or beneficiary of such a scheme

Disqualifiers

Patient already included in a study on DOCCU

Patient excluded from organized screening (cervical cancer, hysterectomy).

Patient's opposition to participating in the study

Trial design

Treatments tested in this trial

  • participation of the general practitioner

Treatment groups

11,200 Participants
are divided into 2 treatment groups